Using a treatment that activates the peripheral immune system in an animal model of amyloidosis, the authors show that monocyte-derived macrophages can modify Alzheimer’s disease progression via a TREM2-independent mechanism.
- Raz Dvir-Szternfeld
- Giulia Castellani
- Michal Schwartz